Literature DB >> 17699270

Chronic nephropathies of cocaine and heroin abuse: a critical review.

Jared A Jaffe1, Paul L Kimmel.   

Abstract

Renal disease in cocaine and heroin users is associated with the nephrotic syndrome, acute glomerulonephritis, amyloidosis, interstitial nephritis, and rhabdomyolysis. The pathophysiologic basis of cocaine-related renal injury involves renal hemodynamic changes, glomerular matrix synthesis and degradation, and oxidative stress and induction of renal atherogenesis. Heroin is the most commonly abused opiate in the United States. Previous studies identified a spectrum of renal diseases in heroin users. The predominant renal lesion in black heroin users is focal segmental glomerulosclerosis and in white heroin users is membranoproliferative glomerulonephritis. Although the prevalence of heroin use in the United States has increased, the incidence of "heroin nephropathy" has declined. Because reports of heroin nephropathy predated the surveillance of hepatitis C virus and HIV, the varied findings might be related to the spectrum of viral illnesses that are encountered in injection drug users. Socioeconomic conditions, cultural and behavioral practices, or differences in genetic susceptibilities may be more associated with the development of nephropathy in heroin users than the drug's pharmacologic properties. Administration of cocaine in animal models results in nonspecific glomerular, interstitial, and tubular cell lesions, but there is no animal model of heroin-associated renal disease. The heterogeneity of responses that are associated with heroin is not consistent with a single or simple notion of nephropathogenesis. There are no well-designed, prospective, epidemiologic studies to assess the incidence and the prevalence of renal disease in populations of opiate users and to establish the validity of a syndrome such as heroin nephropathy. It is concluded although there is a paucity of evidence to support a heroin-associated nephropathy, the evidence from in vitro cellular and animal studies to support the existence of cocaine-induced renal changes is more convincing.

Entities:  

Mesh:

Year:  2006        PMID: 17699270     DOI: 10.2215/CJN.00300106

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  38 in total

1.  Nephropathology quiz page.

Authors:  Helen Liapis
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

2.  Risk factors for kidney disease among HIV-1 positive persons in the methadone program.

Authors:  Bartłomiej Matłosz; Ewa Pietraszkiewicz; Ewa Firląg-Burkacka; Ewa Grycner; Andrzej Horban; Justyna D Kowalska
Journal:  Clin Exp Nephrol       Date:  2018-09-14       Impact factor: 2.801

3.  Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease.

Authors:  Joshua D Bundy; Lydia A Bazzano; Dawei Xie; Janet Cohan; Jacqueline Dolata; Jeffrey C Fink; Chi-Yuan Hsu; Kenneth Jamerson; James Lash; Gail Makos; Susan Steigerwalt; Xue Wang; Katherine T Mills; Jing Chen; Jiang He
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-07       Impact factor: 8.237

4.  The Changing Spectrum of Heroin-Associated Kidney Disease.

Authors:  Sanjeev Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-15       Impact factor: 8.237

5.  Illicit drug use, hypertension, and chronic kidney disease in the US adult population.

Authors:  Sanjeev K Akkina; Ana C Ricardo; Amishi Patel; Arjun Das; Lydia A Bazzano; Carolyn Brecklin; Michael J Fischer; James P Lash
Journal:  Transl Res       Date:  2012-06-23       Impact factor: 7.012

Review 6.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

Review 7.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

8.  Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Authors:  Gregory M Lucas; Yuezhou Jing; Mark Sulkowski; Alison G Abraham; Michelle M Estrella; Mohamed G Atta; Derek M Fine; Marina B Klein; Michael J Silverberg; M John Gill; Richard D Moore; Kelly A Gebo; Timothy R Sterling; Adeel A Butt
Journal:  J Infect Dis       Date:  2013-07-31       Impact factor: 5.226

Review 9.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.